Table 3.
Framingham | ARIC | |
---|---|---|
PR interval, >200 ms | ||
Age- and sex-adjusted* | 1.24 (0.72-2.15) | 1.37 (1.04-1.82) |
Multivariable-adjusted† | 1.21 (0.69-2.11) | 1.36 (1.02-1.81) |
P-wave duration, >120 ms | ||
Age- and sex-adjusted* | 1.70 (1.26-2.30) | 1.71 (1.39-2.11) |
Multivariable-adjusted† | 1.54 (1.13-2.11) | 1.55 (1.25-1.93) |
Maximum P-wave area, ≥95th percentile | ||
Age- and sex-adjusted* | 1.21 (0.69-2.12) | 1.52 (1.05-2.21) |
Multivariable-adjusted† | 1.21 (0.68-2.15) | 1.35 (0.92-1.98) |
P-wave terminal force, >4000 μV·ms | ||
Age- and sex-adjusted* | 1.09 (0.78-1.52) | 1.75 (1.39-2.20) |
Multivariable-adjusted† | 1.00 (0.71-1.40) | 1.56 (1.24-2.00) |
Hazard ratios are for 10-year follow-up. Framingham indicates Framingham Heart Study; ARIC, Atherosclerosis Risk in Communities Study. Events and P-wave indices referent as described by text.
Includes adjustment for race in ARIC.
Multivariable-adjusted for age, sex, race (in ARIC), current smoking, height, weight, systolic and diastolic blood pressures, heart rate, total/HDL cholesterol, ECG-based LVH, diabetes, history of myocardial infarction, and prevalent heart failure.